BioCardia
BCDA
12 hedge funds and large institutions have $624K invested in BioCardia in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
129% more capital invested
Capital invested by funds: $272K → $624K (+$352K)
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
2.52% more ownership
Funds ownership: 2.73% → 5.24% (+2.5%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
8% less funds holding
Funds holding: 13 → 12 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$121K |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
+$85.9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$38.9K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$37.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$15.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.2K |
| 2 |
JP Morgan Chase
New York
|
-$1.96K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.17K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$358 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$17 |
BCDA Hedge Fund Activity: Q1 2025 in Review
12 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q1 2025, worth a combined $624K — up 129% from $272K a quarter earlier.
Fund positioning in BCDA was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 3 trimmed.
The largest buyer was CM Management, adding an estimated $121K. The largest seller was Morgan Stanley, cutting an estimated $2.2K.
- 12 institutional investors held BioCardia (BCDA) as of Q1 2025, down from 13 in Q4 2024.
- Funds reported $624K of BioCardia stock for Q1 2025, up 129% quarter-over-quarter.
- 2 funds opened new BioCardia positions in Q1 2025 and 2 closed out, a net change of 0 holders.
- The largest BioCardia buyer in Q1 2025 was CM Management, an estimated $121K added.
- The largest BioCardia seller in Q1 2025 was Morgan Stanley, an estimated $2.2K sold.
Based on aggregated 13F filings for Q1 2025.